Key facts
- AcuSurgical’s last known valuation is $10.6M (Oct 2023).
- It has raised $7.4M; the latest was Later Stage VC ($1.3M) in Jan 2025.
- Notable investors include Bpifrance, UI Investissement, Supernova Invest, IRDI Capital Investissement, Korys Investments — 10 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for AcuSurgical
- ·The full record, as it builds
Funding rounds
No funding rounds for AcuSurgical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About AcuSurgical
Developer of retinal microsurgery device designed to give surgeons the tools to succeed in any eye operations. The company's device is a robotic surgical assistant dedicated to the treatment of retinal diseases such as age-related macular degeneration, enabling surgeons to increase the precision of current procedures, filter tremors, and augment visualization.
- Sector
- Healthcare
- HQ
- Montpellier, France
- Founded
- 2020
- Employees
- 41
- Website
- acusurgical.com/
- Ownership
- Privately Held (backing)
AcuSurgical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in AcuSurgical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on AcuSurgical in its N-PORT filings yet. We sweep new filings monthly.